Keywords: scripts, gsk, avandia, continue, fall, ims, health

US scripts of GSK's Avandia continue to fall

Article | 02 July 2007

Print This

IMS Health's US prescription data for the week to June 15 shows the ongoing impact on prescribing levels of GlaxoSmithKline's anti-diabetes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in